You have 9 free searches left this month | for more free features.

Opposing effects on glucose metabolism

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolism Disorder, Glucose, Metabolism Disorder, Lipid, Vitiligo Trial in Xi'an (Collecting blood samples)

Completed
  • Metabolism Disorder, Glucose
  • +2 more
  • Collecting blood samples
  • Xi'an, Shaanxi, China
    Xijing Hospital
Jul 21, 2023

Glucose Tolerance Impaired Trial (20% fat meal, 40% fat meal, 60% fat meal)

Not yet recruiting
  • Glucose Tolerance Impaired
  • 20% fat meal
  • +3 more
  • (no location specified)
Jun 14, 2023

Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Nov 11, 2022

Glucose on Metabolism and Clinical Symptoms of Parkinson's

Recruiting
  • Parkinson Disease
  • +2 more
  • Oral Glucose Tolerance Test
  • Placebo Oral Glucose Tolerance Test
  • Kiel, Germany
    Department for Neurology, University of Kiel
Aug 10, 2023

Monitoring Sleep, Wellbeing, and Glucose Metabolism in PGY1s

Recruiting
  • Sleep
  • Glucose Metabolism Disorders
  • CGM
  • +2 more
  • Singapore, (No States Listed), Singapore
    National University of Singapore
Jan 22, 2023

Autoimmune Encephalitis Trial in Paris (FDG PET)

Not yet recruiting
  • Autoimmune Encephalitis
  • FDG PET
  • Paris, France
    Hospital Pitie Salpetriere
Oct 16, 2023

PreDiabetes, Impaired Glucose Tolerance, Glucose Metabolism Disorders Trial in Venlo (Apple Polyphenols, Control)

Terminated
  • PreDiabetes
  • +2 more
  • Apple Polyphenols
  • Control
  • Venlo, Limburg, Netherlands
    Villa Flora
Jul 18, 2023

Nutrition, Healthy, Dietary Deficiency, Bone Resorption Trial in Palermo (Control Group, Biostimulated group)

Completed
  • Nutrition, Healthy
  • +5 more
  • Control Group
  • Biostimulated group
  • Palermo, Italy
    NABbio, STEBICEF department
Jul 30, 2023

Bariatric Surgery on Glucose Metabolism in Chinese Obese and

Not yet recruiting
  • Diabete Type 2
  • Obesity
  • oral glucose tolerance test
  • MRI
  • (no location specified)
Jun 7, 2023

Glucagon-Like Peptide-1 Receptor, Metformin, Obesity, Abdominal Trial in Shanghai (Liraglutide, Semaglutide, Metformin)

Recruiting
  • Glucagon-Like Peptide-1 Receptor
  • +7 more
  • Shanghai, Shanghai, China
    Ren Ji Hospital, Shanghai Jiao Tong University School of Medicin
Mar 9, 2023

Dietary Impact on Continuous Glucose Monitoring

Not yet recruiting
  • Glucose Metabolism Disorders
  • +3 more
    • (no location specified)
    Apr 25, 2023

    Postpartum Glucose Metabolism Abnormalities in Gestational

    Recruiting
    • Gestational Diabetes Mellitus
    • Questionnaire survey and specimen collection
    • Hangzhou, Zhejiang, China
      Women's Hospital School Of Medicine Zhejiang University
    Jan 1, 2023

    Potential Abnormality of Glucose Tolerance, Appetite Disorders Trial in Athens (Glucose as reference food, Control juice, Juice

    Active, not recruiting
    • Potential Abnormality of Glucose Tolerance
    • Appetite Disorders
    • Glucose as reference food
    • +5 more
    • Athens, Attica, Greece
      Agricultural University of Athens
    Jan 19, 2023

    Diabetes, Type 1, Hypoglycemia Unawareness Trial (Dichloroacetate)

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • Hypoglycemia Unawareness
    • (no location specified)
    Oct 3, 2022

    Impaired Glucose Metabolism in Alzheimer's Disease

    Recruiting
    • Alzheimer Disease
    • Deuterium metabolic imaging
    • Aarhus, Denmark
      Aarhus University
    Jan 5, 2023

    Sleep Deprivation, Obesity, Glucose Intolerance Trial (Chronic Sleep Restriction)

    Not yet recruiting
    • Sleep Deprivation
    • +4 more
    • Chronic Sleep Restriction
    • (no location specified)
    Mar 7, 2023

    Endocrine Glucose & Lipids Metabolism and Brain

    Recruiting
    • Brain Aging Related Conditions
    • Observation study without intervention
    • Jinan, Shandong, China
      Shandong Provincial Hospital Affiliated to Shandong First Medica
    Oct 4, 2023

    Obstructive Sleep Apnea, Pre-diabetes Trial (CPAP withdrawal)

    Not yet recruiting
    • Obstructive Sleep Apnea
    • Pre-diabetes
    • CPAP withdrawal
    • (no location specified)
    Sep 6, 2022

    Diabete Type 2 Trial in New Haven (Intensification of insulin regimen/Nutrition)

    Suspended
    • Diabete Type 2
    • Intensification of insulin regimen/Nutrition
    • New Haven, Connecticut
      Yale New Haven Hospital
    Jan 13, 2023

    Obesity Trial in Hellerup (LEAP-2 Protein, Human)

    Recruiting
    • Obesity
    • LEAP-2 Protein, Human
    • Hellerup, Capital Region, Denmark
      Center for Clinical Metabolic Research, Gentofte Hospital
    Oct 31, 2022

    Diabetes Type 2 Trial in Islamabad (Metformin)

    Enrolling by invitation
    • Diabetes Mellitus Type 2
    • Islamabad, Federal, Pakistan
      Islamabad Medical and Dental College
    Nov 5, 2023

    Chronic Kidney Diseases, Diabetes, PreDiabetes Trial in Vienna (Therapeutic carbohydrate restriction combined with an

    Recruiting
    • Chronic Kidney Diseases
    • +3 more
    • Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor
    • Vienna, Austria
      6th Medical Department with Nephrology and Dialysis, Clinik Otta
    Oct 16, 2023

    Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)

    Active, not recruiting
    • Obesity
    • Oral Glucose Tolerance Test (OGTT)
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 18, 2022

    Appetitive Behavior, Glucose Metabolism Disorders Trial in London (Splenda drink, Maltodextrin drink, High carbohydrate

    Completed
    • Appetitive Behavior
    • Glucose Metabolism Disorders
    • Splenda drink
    • +2 more
    • London, United Kingdom
      King's College London
    Mar 30, 2023

    Non-Alcoholic Fatty Liver Disease (NAFLD), Disorders of Glucose Metabolism, Type 2 Diabetes Trial in Shanghai (Intermittent

    Completed
    • Non-Alcoholic Fatty Liver Disease (NAFLD)
    • +3 more
    • Intermittent calorie restriction
    • 25kcal/kg/d diet
    • Shanghai, China
      Zhongshan Hospital, Fudan University
    Aug 5, 2022